Mistletoe extract-induced effects on immunocompetent cells: In vitro studies

Anti-Cancer Drugs

Volumn 8, Issue SUPPL. 1, 1997, Pages

  Stein, G M ^a   Berg, P A ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Macrophages; Mistletoe; Monocytes; Stimulation of immune system; T helper cells; T helper 1 cytokines; T helper 2 cytokines

Indexed keywords

CD14 ANTIGEN; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; PLANT EXTRACT; UNCLASSIFIED DRUG; VISCOTOXIN; VISCUM ALBUM LECTIN; VISCUM ALBUM LECTIN I; VISCUM ALBUM LECTIN II; VISCUM ALBUM LECTIN III;

COLORECTAL TUMOR; CONFERENCE PAPER; CYTOTOXICITY; HELPER CELL; HOST; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; MACROPHAGE; MONOCYTE; PERIPHERAL LYMPHOCYTE; PINE; PRIORITY JOURNAL; TREE; VISCUM ALBUM;

EID: 0031009209     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199704001-00009     Document Type: Conference Paper

References (19)

1. Franz H: Components from mistletoe (Viscum album L.) for possible use as drugs. Die Pharmazie 1985, 40: 97-104.
2. Beuth J, Ko HL, Gabius HJ, Burrichter H, Oette K, Pulverer G: Behaviour of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients. Clin Invest 1992, 70: 658-661.
3. Büssing A, Suzart K, Bergmann J, Pfuller U, Schietzel M, Schweizer K: Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins. Cancer Lett 1996, 99: 59-67.
4. Jung ML, Ribéreau-Gayon G, Beck JP, Baudino D: Characterization of cytotoxic proteins from mistletoe (Viscum album L.). Cancer Lett 1990, 51: 103-108.
5. Stettin A, Schultze JL, Stechemesser E, Berg PA: Anti-mistletoeantibodies are produced in patients during therapy with an aqueous mistletoe extract derived from Viscum album L. and neutralize lectin-induced cytotoxicity in vitro. Klin Wochenschr 1990, 68: 896-900.
6. Schultze JL, Stettin A, Berg PA: Demonstration of specifically sensitized lymphocytes in patients treated with an aqueous mistletoe extract (Viscum album L). Klin Wochenschr 1991, 69: 397-403.
7. Klett CY. Anderer FA: Activation of natural-killer cytotoxicity of human blood monocytes by a low molecular weight component from Viscum album extract. Arzneim-Forsch Drug Res 1989, 39: 1580-1585.
8. Kuttan G, Kuttan R: Immunological mechanism of action of the tumor reducing peptide from mistletoe extract (NSC 635089) cellular proliferation. Cancer Lett 1992, 66: 123-130.
9. Hajto T, Hostanska K, Frei K, Rordorf C, Gabius HJ: Increased secretion of TNF-α, IL-1 and IL-6 by human mononuclear cells exposed to β-galactoside-specific lectin from clinically applied mistletoe extract. Cancer Res 1990, 50: 3322-3326.
10. Stein G, Berg PA: Non-lectin component in a fermented extract from Viscum album L. grown on pines induces proliferation of lymphocytes from healthy and allergic individuals in vitro. Eur J Clin Pharmacol 1994, 47: 33-38.
11. Stein G, Berg PA: Mistletoe extract-induced proliferation and cytokine release in cultures of lymphocytes from untreated individuals in vitro. In: Proceedings the 1st World Meeting on Pharmaceutics. Biopharmaceutics. Pharmaceutical Technology: Budapest; May 1995:891-892.
12. Stein GM, Berg PA: Evaluation of the stimulatory activity of a fermented mistletoe lectin-1 free mistletoe extract on T-helper cells and monocytes in healthy individuals in vitro. ArzneimForsch/Drug Res 1996, 46: 635-639.
13. June CH, Bluestone JA, Nadler LM, Thompson CB: The B7 and CD28 receptor families. Immunol Today 1994, 15: 321-332.
14. Mosman TR, Coffman RL: Heterogeneity of cytokine secretion patterns and function of helper T-cells. Adr Immunol 1989, 46: 111-147.
15. H2 responses: a key role for the 'natural' immune response? Immunol Today 1992, 13: 379-381.
16. Stein GM, Meink H, Durst J, Berg PA: The release of cylokines by a fermented lectin-1 (ML-1) free mistletoe extract reflects differences in the reactivity of PBMC in healthy and allergic individuals and tumor patients. Eur J Clin Pharmacol 1996, 51: 247-252.
17. Elsasser-Beile U, von Kleist S, Sauther W, Gallati H, Schulte Monting J: Impaired cytokine production in whole blood cell cultures of patients with gynaecological carcinomas in different clinical stages. Br J Cancer 1993, 68: 32-36.
18. Elsasser-Beile U, von Kleisi S, Stahle W, Schurhammer-Furmann C, Schulte Monting J Gallati H: Cytokine levels in whole blood cell culures as parameters of the cellular immunologic activity in patients with malignant melanoma and basal cell carcinoma Cancer 1993, 71: 231-236.
19. Zielinski CC, Mueller C, Tyl E, Tichatschek E, Kubista E, Spona J: Impaired production of tumor necrosis factor in breast cancer. Cancer 1990, 66: 1944-1948.